Skip to content

INFU · AMEX

InfuSystem Holdings (INFU) Stock Price & Fundamentals

$200.37−0.28%−$0.57End-of-day price as of Oct 9, 2026

InfuSystem Holdings (INFU) closed at $200.37 on Oct 9, 2026, down 0.28% from the previous close of $200.94.

Share price, past year

1Y −11.03%

52-week range $189.45 – $225.78. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$200.37
Sep 30, 2026$199.63
Aug 31, 2026$193.19
Jul 31, 2026$197.06
Jun 30, 2026$203.52
May 29, 2026$218.42
Apr 30, 2026$216.74
Mar 31, 2026$209.95
Feb 27, 2026$209.04
Jan 30, 2026$216.99
Dec 31, 2025$213.43
Nov 28, 2025$219.12
Oct 31, 2025$223.42

Key statistics

Market cap
$3.99B
P/E (TTM)
500.9
EPS (TTM)
$0.40
Revenue (TTM)
$143.34M
Net income (TTM)
$8.54M
Shares outstanding
19.9M
Dividend yield
—
52-week range
$189.45 – $225.78

InfuSystem Holdings's market cap is $3.99B, based on a share price of $200.37 and 19.9M shares outstanding as of Jun 30, 2026.

Financials

InfuSystem Holdings reported revenue of $143.44M for fiscal 2025, up 6.36% from fiscal 2024.

InfuSystem Holdings earned net income of $6.63M in fiscal 2025, a net margin of 4.6%.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
InfuSystem Holdings annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$143.44M+6.4%$6.63M4.6%$0.31$23.85M
FY2024ended Dec 31, 2024$134.86M+7.2%$2.35M1.7%$0.11$19.37M
FY2023ended Dec 31, 2023$125.79M+14.4%$872.00K0.7%$0.04$10.20M
FY2022ended Dec 31, 2022$109.91M+7.4%$18.00K0.0%$0.00$16.54M
FY2021ended Dec 31, 2021$102.38M+5.1%$1.42M1.4%$0.06$17.34M
FY2020ended Dec 31, 2020$97.39M+20.1%$17.33M17.8%$0.80$19.19M
FY2019ended Dec 31, 2019$81.12M+20.8%$1.36M1.7%$0.07$10.95M
FY2018ended Dec 31, 2018$67.14M−5.5%−$1.10M−1.6%−$0.05$11.11M
FY2017ended Dec 31, 2017$71.08M+0.8%−$20.71M−29.1%−$0.91$7.61M
FY2016ended Dec 31, 2016$70.50M—−$222.00K−0.3%−$0.01$7.74M
InfuSystem Holdings quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$36.93M$3.23M$0.15
Q1 FY2026ended Mar 31, 2026$33.68M$1.02M$0.05
Q4 FY2025ended Dec 31, 2025$36.23M$2.04M$0.09
Q3 FY2025ended Sep 30, 2025$36.49M$2.26M$0.11
Q2 FY2025ended Jun 30, 2025$36.00M$2.60M$0.12
Q1 FY2025ended Mar 31, 2025$34.72M−$267.00K−$0.01
Q4 FY2024ended Dec 31, 2024$33.85M$933.00K$0.05
Q3 FY2024ended Sep 30, 2024$35.32M$1.81M$0.08

Company profile

Name
InfuSystem Holdings, Inc
Ticker
INFU
Exchange
AMEX
Industry (SEC SIC)
Surgical & Medical Instruments & Apparatus
Headquarters
3851 West Hamlin Road, Rochester Hills, MI 48309
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001337013

Recent SEC filings

Frequently asked questions

What is InfuSystem Holdings's stock price?

InfuSystem Holdings (INFU) closed at $200.37 on Oct 9, 2026, down 0.28% from the previous close of $200.94.

What is InfuSystem Holdings's market cap?

InfuSystem Holdings's market cap is $3.99B, based on a share price of $200.37 and 19.9M shares outstanding as of Jun 30, 2026.

How much revenue does InfuSystem Holdings make?

InfuSystem Holdings reported revenue of $143.44M for fiscal 2025, up 6.36% from fiscal 2024.

What is INFU's P/E ratio?

InfuSystem Holdings's price-to-earnings ratio is 500.9, based on trailing twelve-month diluted EPS of $0.40.

Does InfuSystem Holdings pay a dividend?

InfuSystem Holdings's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from InfuSystem Holdings, Inc's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures